Ovarian Cancer GOG 186J
March 13, 2013
Location: The Hospital of Central Connecticut
A Randomized Phase IIB Evaluation of Weekly Paclitaxel Plus Pazopanib Versus Weekly Paclitaxel Plus Placebo in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma.